NCT03414229 2025-05-02A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced SarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting30 enrolled 11 charts